Therefore, we believe not considering BRCA1 and TP53 as DEGs in IDC and LC samples could be owed to the inter-individual heterogeneity rather than the irrelevance of the genes analyzed to IDC and LC (S1 Fig). The gene discussed is TP53; the disease is laryngotracheoesophageal cleft.